An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma.
about
Metabolism of kidney cancer: from the lab to clinical practiceState of the science: an update on renal cell carcinomaFundamentals of cancer metabolismMetabolic, autophagic, and mitophagic activities in cancer initiation and progressionCullin 3 Ubiquitin Ligases in Cancer Biology: Functions and Therapeutic ImplicationsMitochondrial metabolic remodeling in response to genetic and environmental perturbationsThe Tumorigenic Roles of the Cellular REDOX Regulatory SystemsMolecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease interventionDecade in review-kidney cancer: discoveries, therapies and opportunitiesGenetically-defined metabolic reprogramming in cancerProtein lysine acylation and cysteine succination by intermediates of energy metabolismp62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogrammingDefects in mitochondrial metabolism and cancerOncometabolites: Unconventional triggers of oncogenic signalling cascadesChanging perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agentsThe Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancerCRNDE: A Long Non-Coding RNA Involved in CanceR, Neurobiology, and DEvelopmentThe Keap1-Nrf2 system in cancers: stress response and anabolic metabolismMechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative diseaseMetabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinomaMetabolic reprogramming: a cancer hallmark even warburg did not anticipateIntegrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers.An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.The succinated proteome.Hereditary leiomyomatosis and renal cell carcinoma.Systematic Analysis of the Expression of the Mitochondrial ATP Synthase (Complex V) Subunits in Clear Cell Renal Cell Carcinoma.Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells.Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus-associated hepatocellular carcinoma.The oncometabolite fumarate promotes pseudohypoxia through noncanonical activation of NF-κB signalingAerobic glycolysis: a novel target in kidney cancer.Succination of Keap1 and activation of Nrf2-dependent antioxidant pathways in FH-deficient papillary renal cell carcinoma type 2.Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressorsNRF2 and cancer: the good, the bad and the importance of context.The Succinated Proteome of FH-Mutant TumoursOncometabolites: linking altered metabolism with cancer.The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling.Fumarate induces redox-dependent senescence by modifying glutathione metabolism.Targeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancer.Molecular pathways: Fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer.Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.
P2860
Q24600512-0CEFCF2E-3A5B-4F59-93D6-2F3DDD75517AQ24630685-B7083DE8-6343-4994-8D16-36FCCD75A8EDQ26744062-E08D2F12-7B11-4459-80B3-28840F4061BCQ26745503-BF078E5A-AF7C-465F-89BF-456757CD42FAQ26747274-52D5F012-0C7B-495C-982A-12DED2A00912Q26747718-D86774EF-29D8-42E3-B147-DC752C4E3CD1Q26774894-5A690EFC-01BB-4310-A058-D3ADCF1F8F0DQ26778356-A612621B-903A-41BB-A839-F1D28985BFD5Q26853533-81C8D8BD-3109-4F47-91FA-D9E726AA6E69Q27004739-D23915BC-1A4D-451F-9BCE-F5BBFC7A6B53Q27027406-5D295E6D-E3C5-4218-AC8C-9CF4DD013C08Q27644656-02289C4D-5E48-40CB-A0D2-1A7A986F43E1Q27694117-F52EA3D2-72E3-423B-AFD4-2082991E60CCQ28069594-C198B604-6861-42B2-90D9-946EA6A3746AQ28073524-2060BAC3-3F79-4BD0-95BD-61159174D324Q28387975-A258794F-651B-4FA5-8051-EDEBE23A8380Q28391523-2900AD4E-5256-491D-8FB7-B56A1A2B7557Q28392347-1797B9A9-BA09-46F1-9152-058484144209Q28394732-178F2707-BDB0-4023-A98F-DDD63378E580Q28535371-FC3707E8-9045-4593-B165-236C0751FB80Q29617612-AC69B226-ECD0-47DC-9744-4E691E7735A0Q31038292-9759294C-2756-434D-A073-CCC0F8FA3450Q33274526-65D239CD-C365-43FA-BA8C-A8C590E203C1Q33684446-7CEE381E-683F-4895-BFA9-1C6CA3E76775Q33817755-D765A2DB-A41F-42D7-AEFA-4BBA4BC3AEB9Q33869708-F79EBE2B-5C09-4C08-908C-51FCF778293EQ33938894-B3205BF7-F1E4-460E-9D4C-F2EAB907DAB7Q34079748-D3444D34-7F30-4A85-B938-2B04ED028583Q34107403-175A0D1D-AC7E-4ED5-8B35-FBEEFB6C2D1EQ34194088-2BE955CA-4BC7-4DD4-A115-6CE810D3A68EQ34225909-984E12BB-A39E-44B3-9F03-C66B35D9614BQ34279708-7B6CE34F-FFDC-4B93-892C-0E1A698544CCQ34289003-DAD2C0A8-A6C1-4656-8B48-20DFE5892158Q34318225-E0A45377-F58E-4E69-8951-2D26036A1730Q34368256-354B5B93-3326-44CA-8570-696143B8C85CQ34762767-9FF74CC3-0C1D-45B3-80C0-586F97A36A19Q35121732-C2C60DFD-41AD-49EE-ACD0-5DA657FDEA05Q35278899-865B1A46-387F-4F8D-A72A-7867D3A8DBECQ35659640-795F8F9F-E13C-413B-9D5A-96A9C2B67131Q35859412-7CF01DAA-DF9E-4BA3-A721-3B4685218D12
P2860
An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
An antioxidant response phenot ...... apillary renal cell carcinoma.
@ast
An antioxidant response phenot ...... apillary renal cell carcinoma.
@en
An antioxidant response phenot ...... apillary renal cell carcinoma.
@nl
type
label
An antioxidant response phenot ...... apillary renal cell carcinoma.
@ast
An antioxidant response phenot ...... apillary renal cell carcinoma.
@en
An antioxidant response phenot ...... apillary renal cell carcinoma.
@nl
prefLabel
An antioxidant response phenot ...... apillary renal cell carcinoma.
@ast
An antioxidant response phenot ...... apillary renal cell carcinoma.
@en
An antioxidant response phenot ...... apillary renal cell carcinoma.
@nl
P2093
P1433
P1476
An antioxidant response phenot ...... apillary renal cell carcinoma.
@en
P2093
Aikseng Ooi
Bernice Wong Hui Min
Betty Gardie
David Petillo
Douglas Whitten
Jing-Chii Wong
Kyle A Furge
Min-Han Tan
Puay Hoon Tan
P304
P356
10.1016/J.CCR.2011.08.024
P577
2011-10-01T00:00:00Z